| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $3,401,389 ) |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01CA253573 | Targeting aberrant anti-apoptotic signaling for prevention of skin cancer | 000 | 5 | NIH | 4/9/2024 | $316,190 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | P20GM139762 | Translational Hearing Center | 001 | 4 | NIH | 3/27/2024 | $1,957,592 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 000 | 4 | NIH | 12/12/2023 | $362,571 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS126418 | Autoresuscitation and SUDEP | 000 | 3 | NIH | 1/10/2024 | $322,790 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R00DC020759 | Subthreshold vestibular stimulation as a strategy for rehabilitation | 000 | 2 | NIH | 1/29/2024 | $248,711 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21DC020773 | Dissecting the sensory hair cell nucleus: Development of a novel method for investigating chromatin interactions (Tn5-Capture) in small cell numbers | 000 | 2 | NIH | 11/16/2023 | $163,688 |
| | 2024 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | NU58DP007612 | Center for Promoting Health and Health Equity-Racial and Ethnic Approaches to Community Health 2 (CPHHE-REACH 2) | 01 | 1 | CDC | 11/30/2023 | $0 |
| | 2024 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | F32DC020102 | Repurposing FDA-Approved MEK Inhibitor Trametinib for Protection Against Cisplatin-Induced Hearing Loss | 000 | 2 | NIH | 1/12/2024 | -$17,135 |
| | 2024 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | P20GM139762 | Translational Hearing Center | 000 | 3 | NIH | 11/3/2023 | $0 |
| | 2024 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | NU58DP007612 | Center for Promoting Health and Health Equity-Racial and Ethnic Approaches to Community Health 2 (CPHHE-REACH 2) | 01 | 1 | CDC | 11/30/2023 | $0 |
| | 2024 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC019918 | Innate Immunity to Spiral Ganglion Neuron Degeneration | 001 | 2 | NIH | 11/14/2023 | -$41,673 |
| | 2024 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21AI173819 | Cholinergic anthelmintics: Tachyphylaxis mechanisms and control in a parasitic nematode model,Brugia malayi | 001 | 2 | NIH | 3/7/2024 | $186,846 |
| | 2024 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R15EY032275 | Novel ocular hypotensive and neuroprotective microparticle-based hydrogen sulfide delivery system | 000 | 1 | NIH | 2/2/2024 | $0 |
| | 2024 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC019918 | Innate Immunity to Spiral Ganglion Neuron Degeneration | 000 | 1 | NIH | 11/14/2023 | -$27,376 |
| | 2024 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21AI159127 | A novel form of light chain gene replacement | 000 | 2 | NIH | 1/30/2024 | $0 |
| | 2024 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R03AG070492 | Characterizing upstream regulators of glucosylceramide metabolism for Parkinson's disease and Lewy Body Dementia | 000 | 2 | NIH | 10/18/2023 | $0 |
| | 2024 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | D1832118 | Health Careers Opportunity Program | 02 | 5 | HRSA | 11/14/2023 | $0 |
| | 2024 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC016807 | Mechanisms of Biological Aging of Cochlear Hair Cells | 000 | 5 | NIH | 4/4/2024 | -$49 |
| | 2024 | 2019 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R15DE028687 | The Role of LPA1 in the Etiology of Periodontal Disease | 000 | 1 | NIH | 3/6/2024 | -$18,267 |
| | 2024 | 2019 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R15DE028687 | The Role of LPA1 in the Etiology of Periodontal Disease | 000 | 1 | NIH | 3/6/2024 | -$52,498 |
|
| Issue Date FY: 2023 ( Subtotal = $12,023,391 ) (Continued on the next page) |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC021070 | Identification and characterization of novel functions for the Usher proteins in the inner ear | 000 | 1 | NIH | 4/27/2023 | $520,111 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | F32DC020102 | Repurposing FDA-Approved MEK Inhibitor Trametinib for Protection Against Cisplatin-Induced Hearing Loss | 001 | 2 | NIH | 2/7/2023 | $1,990 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | F32DC020102 | Repurposing FDA-Approved MEK Inhibitor Trametinib for Protection Against Cisplatin-Induced Hearing Loss | 000 | 2 | NIH | 1/12/2023 | $69,802 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21DC020773 | Dissecting the sensory hair cell nucleus: Development of a novel method for investigating chromatin interactions (Tn5-Capture) in small cell numbers | 000 | 1 | NIH | 10/21/2022 | $181,875 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | F30DC019528 | Repurposing momelotinib for the prevention of aminoglycoside-induced ototoxicity | 000 | 3 | NIH | 1/13/2023 | $37,979 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC019918 | Innate Immunity to Spiral Ganglion Neuron Degeneration | 001 | 2 | NIH | 7/13/2023 | -$445,445 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 000 | 3 | NIH | 12/20/2022 | $362,571 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 001 | 3 | NIH | 1/18/2023 | $40,286 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DK122558 | Skeletal Effects of Type 1 Diabetes | 001 | 4 | NIH | 8/22/2023 | $341,196 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS118731 | Trans-synaptic signaling complex in amygdala pain mechanisms | 000 | 4 | NIH | 8/8/2023 | $530,328 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC016680 | Clinical factors in aminoglycoside-induced ototoxicity | 000 | 5 | NIH | 7/26/2023 | $659,676 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21NS132590 | Structure-Function and Signaling of Glutamate Delta 1 in Pain Mechanism | 001 | 1 | NIH | 9/13/2023 | -$404,250 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21NS132590 | Structure-Function and Signaling of Glutamate Delta 1 in Pain Mechanism | 001 | 1 | NIH | 9/13/2023 | $404,250 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21NS132590 | Structure-Function and Signaling of Glutamate Delta 1 in Pain Mechanism | 000 | 1 | NIH | 5/1/2023 | $404,250 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | NU58DP007612 | Center for Promoting Health and Health Equity-Racial and Ethnic Approaches to Community Health 2 (CPHHE-REACH 2) | 00 | 1 | CDC | 8/28/2023 | $302,891 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | NU58DP007612 | Center for Promoting Health and Health Equity-Racial and Ethnic Approaches to Community Health 2 (CPHHE-REACH 2) | 00 | 1 | CDC | 8/28/2023 | $719,008 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | E1324282 | HPSL - Pharmacy | 000 | 2 | HRSA | 8/22/2023 | $1,000,000 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | E4C24385 | NSL - Baccalaureate Nursing | 000 | 2 | HRSA | 8/22/2023 | $584,920 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | E1119074 | HPSL - Dentistry | 000 | 3 | HRSA | 8/22/2023 | $874,068 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS133050 | Contributions of prion strains and substrains to prion zoonotic potential and evolution | 000 | 1 | NIH | 6/2/2023 | $581,891 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01HL164593 | A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma. | 000 | 1 | NIH | 8/29/2023 | $64,908 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01HL164593 | A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma. | 000 | 1 | NIH | 8/29/2023 | $346,204 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01AI167880 | Redox Regulation of DksA-dependent Borrelia burgdorferi infectivity | 000 | 1 | NIH | 7/26/2023 | $350,000 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01AI167880 | Redox Regulation of DksA-dependent Borrelia burgdorferi infectivity | 000 | 1 | NIH | 7/26/2023 | $74,467 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01CA253573 | Targeting aberrant anti-apoptotic signaling for prevention of skin cancer | 000 | 4 | NIH | 4/19/2023 | $326,175 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | F30DC019528 | Repurposing momelotinib for the prevention of aminoglycoside-induced ototoxicity | 001 | 3 | NIH | 2/7/2023 | $942 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC019918 | Innate Immunity to Spiral Ganglion Neuron Degeneration | 000 | 2 | NIH | 4/27/2023 | $487,118 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01AG077574 | Regulatory Mechanisms Governing BubR1 Protein Stability During Stress and Aging | 000 | 2 | NIH | 4/12/2023 | $298,275 |
|
